Fidelity Investments’s RAPT Therapeutics RAPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.5K Sell
1,936
-2,024
-51% -$16.2K ﹤0.01% 4381
2025
Q1
$38.6K Sell
3,960
-650,171
-99% -$6.35M ﹤0.01% 3971
2024
Q4
$8.27M Sell
654,131
-309
-0% -$3.91K ﹤0.01% 2002
2024
Q3
$10.5M Hold
654,440
﹤0.01% 1903
2024
Q2
$16M Buy
654,440
+1,983
+0.3% +$48.4K ﹤0.01% 1723
2024
Q1
$46.9M Buy
652,457
+172,034
+36% +$12.4M ﹤0.01% 1348
2023
Q4
$95.5M Sell
480,423
-81,989
-15% -$16.3M 0.01% 1034
2023
Q3
$74.8M Buy
562,412
+38,601
+7% +$5.13M 0.01% 1092
2023
Q2
$78.4M Sell
523,811
-33,169
-6% -$4.96M 0.01% 1094
2023
Q1
$81.8M Buy
556,980
+187,953
+51% +$27.6M 0.01% 1059
2022
Q4
$58.5M Sell
369,027
-78,051
-17% -$12.4M 0.01% 1191
2022
Q3
$86.1M Sell
447,078
-64,943
-13% -$12.5M 0.01% 1012
2022
Q2
$74.8M Buy
512,021
+114,183
+29% +$16.7M 0.01% 1083
2022
Q1
$70M Buy
397,838
+116,734
+42% +$20.5M 0.01% 1253
2021
Q4
$82.6M Buy
281,104
+138,463
+97% +$40.7M 0.01% 1193
2021
Q3
$35.4M Buy
+142,641
New +$35.4M ﹤0.01% 1568